Form 4: Zimmer Biomet Director Farrell Reports Acquisition of Phantom Stock Units

Director Michael J. Farrell reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the deferred compensation plan.

Summary

• Michael J. Farrell, a director of Zimmer Biomet Holdings, Inc., reported the acquisition of 244.821 phantom stock units on March 31, 2024.
• These units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The conversion price is 1-for-1, and the units will be settled in cash within sixty days after Farrell's service as a director ends.
• The reporting person directly owns 13,643.29 phantom stock units.
• This amount includes 25.017 phantom stock units accrued on January 31, 2024, under the dividend reinvestment provision of the plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and insider alignment with company performance.

Future Outlook

The phantom stock units will be settled in cash within sixty days after cessation of the reporting person's service as a Director.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and holdings of company directors.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it primarily concerns the director's compensation.
• It provides transparency to shareholders regarding director compensation.

Key Dates